Shopping Cart 0
Cart Subtotal

Global Mycophenolate Mofetil Market Outlook 2017-2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3100

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase


Mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), an inhibitor of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil is marketed under the trade name CellCept and mycophenolate sodium as Myfortic.

The five-year forecast for the mycophenolate mofetil market shows a healthy Compound Annual Growth Rate (CAGR) of 5.3 percent driven by increased demand, according to a new report published by Gen Consulting Company.

The report covers forecast and analysis for the mycophenolate mofetil market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the mycophenolate mofetil market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the mycophenolate mofetil market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global mycophenolate mofetil market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

On the basis of products, the market for mycophenolate mofetil is segmented into Capsule, Tablet, Injection, others. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global mycophenolate mofetil market.

Key Product Types




Key Regions

North America


Asia Pacific

Middle East and Africa

South America

Key Vendors






Concord Biotech

Excella Gmbh


Huadong Medicine

Hubei Teyer

Hunan Warrant




PKU Healthcare

Roche Pharma

RPG Life Sciences

request free sample to get a complete list of companies

Key Questions Answered in this Report

What will the market size be in 2022?

What are the key factors driving the global mycophenolate mofetil market?

What are the challenges to market growth?

Who are the key players in the mycophenolate mofetil market?

What are the market opportunities and threats faced by the key players?


Table Of Content


Part 1. Exclusive Summary

Part 2. Methodology

2.1 Research Methodology

2.2 Geographic Scope

2.3 Years Considered

Part 3. Introduction

3.1 Product Overview

3.2 Mechanisms of Action

3.3 Manufacturing Process

3.3.1 Raw Materials

3.3.2 Cost Analysis

Part 4. Competitive Landscape

4.1 Global Mycophenolate Mofetil Market, by Volume 2012-2017

4.1.1 Overview

4.1.2 Global Mycophenolate Mofetil Market, by Volume, by Company

4.1.3 Top 10 Companies by Volume Share

4.2 Global Mycophenolate Mofetil Market, by Revenue 2012-2017

4.2.1 Overview

4.2.2 Global Mycophenolate Mofetil Market, by Revenue, by Company

4.2.3 Top 10 Companies by Revenue Share

Part 5. Market Dynamics

5.1 Market Drivers

5.2 Challenges

Part 6. Segmentation by Application

6.1 Overview

6.2 Capsule

6.3 Tablet

6.4 Injection

Part 7. API Supply by Region

7.1 Global Mycophenolate Mofetil Volume by Region

7.1.1 North America

7.1.2 Europe

7.1.3 Asia-Pacific

7.2 Global Mycophenolate Mofetil Revenue by Region

7.2.1 North America

7.2.2 Europe

7.2.3 Asia-Pacific

Part 8. Consumption Pattern

8.1 North America

8.1.1 Overview

8.1.2 by Application

8.1.3 by Country (U.S., Canada, Mexico, etc.)

8.2 Europe

8.2.1 Overview

8.2.2 by Application

8.2.3 by Country (Germany, UK, France, Spain, Italy, etc.)

8.3 Asia-Pacific

8.3.1 Overview

8.3.2 by Application

8.3.3 by Country (China, Japan, Korea, India, etc.)

8.4 MEA

8.4.1 Overview

8.4.2 by Application

8.4.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)

8.5 South America

8.5.1 Overview

8.5.2 by Application

8.5.3 by Country (Brazil, Argentina, Colombia, etc.)

Part 9. Mycophenolate Mofetil Market Forecast

9.1 Global Mycophenolate Mofetil Market Size 2017-2022

9.2 Global Mycophenolate Mofetil Market by Region 2017-2022

9.2.1 North America

9.2.2 Europe

9.2.3 Asia-Pacific

9.3 Global Mycophenolate Mofetil Consumption 2017-2022

9.4 Global Mycophenolate Mofetil Market by Application 2017-2022

Part 10. Company Profiles

10.1 Apotex

10.1.1 Business Overview

10.1.2 Products Offered

10.1.3 Financials

10.2 Arevipharma

10.3 Baiqi

10.4 Biocon

10.5 CCSB

10.6 Concord Biotech

10.7 Excella Gmbh

10.8 Formosa

10.9 Huadong Medicine

10.10 Hubei Teyer

10.11 Hunan Warrant

10.12 Livzon

10.13 Lunan

10.14 NCPC

10.15 PKU Healthcare

10.16 Roche Pharma

10.17 RPG Life Sciences


Part 11. Industry Activity

11.1 M&As, JVs and Partnership

11.2 Other Developments

Part 12. Appendix

12.1 Abbreviations

12.2 Disclaimer

Licence Rights

Single License

allows one individual to access the purchased report

Site License

allows five individuals to access the purchased report

Enterprise License

allows all employees of an organization to access the purchased report

Section Purchase

To know more information on Purchase by Section, please send a mail to